Letter: Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.

IF 5.9 2区医学 Q1 UROLOGY & NEPHROLOGY

Journal of Urology Pub Date : 2024-11-01 Epub Date: 2024-07-31 DOI:10.1097/JU.0000000000004174

Ali Furkan Batur

引用次数: 0

查看原文本刊更多论文

信TAS-303 对女性压力性尿失禁患者的疗效和安全性：2期随机、双盲、安慰剂对照试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Urology 医学-泌尿学与肾脏学

CiteScore

11.50

自引率

7.60%

发文量

3746

审稿时长

2-3 weeks

期刊介绍： The Official Journal of the American Urological Association (AUA), and the most widely read and highly cited journal in the field, The Journal of Urology® brings solid coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of urology. This premier journal presents investigative studies on critical areas of research and practice, survey articles providing short condensations of the best and most important urology literature worldwide, and practice-oriented reports on significant clinical observations.